These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1378466)

  • 1. Mechanism of Helicobacter pylori pathogenesis: focus on mucus.
    Slomiany BL; Slomiany A
    J Clin Gastroenterol; 1992; 14 Suppl 1():S114-21. PubMed ID: 1378466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data.
    Slomiany BL; Piotrowski J; Slomiany A
    Arzneimittelforschung; 1997 Apr; 47(4A):475-82. PubMed ID: 9205747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucus and H. pylori.
    Allen A; Newton J; Oliver L; Jordan N; Strugala V; Pearson JP; Dettmar PW
    J Physiol Pharmacol; 1997 Sep; 48(3):297-305. PubMed ID: 9376612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of mucus in gastric mucosal protection.
    Slomiany BL; Slomiany A
    J Physiol Pharmacol; 1991 Jun; 42(2):147-61. PubMed ID: 1782415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological aspects of the cytotoxic action of Helicobacter pylori.
    Taniguchi Y; Ido K; Kimura K; Satoh K; Yoshida Y; Takimoto T; Kihira K; Ookawara S; Mato M
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S17-21. PubMed ID: 7537615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Helicobacter pylori glycosulfatase activity toward gastric sulfomucin by nitecapone.
    Murty VL; Piotrowski J; Morita M; Slomiany A; Slomiany BL
    Biochem Int; 1992 May; 26(6):1091-9. PubMed ID: 1632804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosulfatase activity of H. pylori toward human gastric mucin: effect of sucralfate.
    Slomiany BL; Murty VL; Piotrowski J; Grabska M; Slomiany A
    Am J Gastroenterol; 1992 Sep; 87(9):1132-7. PubMed ID: 1381553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sucralfate counteracts the inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide.
    Slomiany A; Piotrowski J; Slomiany BL
    Scand J Gastroenterol Suppl; 1995; 210():77-81. PubMed ID: 8578214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide a virulence factor of Helicobacter pylori: effect of antiulcer agents.
    Piotrowski J
    J Physiol Pharmacol; 1998 Mar; 49(1):3-24. PubMed ID: 9594407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cagA+ and cagA- strains of Helicobacter pylori on the human gastric mucus layer thickness.
    Al-Marhoon MS; Nunn S; Soames RW
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1246-52. PubMed ID: 16048574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroprotective agents in mucosal defense against Helicobacter pylori.
    Slomiany BL; Murty VL; Piotrowski J; Slomiany A
    Gen Pharmacol; 1994 Sep; 25(5):833-41. PubMed ID: 7835626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosulfatase activity of Helicobacter pylori towards gastric sulfomucin: effect of nitecapone.
    Slomiany BL; Murty VL; Piotrowski J; Morita M; Slomiany A
    J Physiol Pharmacol; 1993 Mar; 44(1):7-16. PubMed ID: 8518427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pH on Helicobacter pylori binding to human gastric mucins: identification of binding to non-MUC5AC mucins.
    Lindén S; Mahdavi J; Hedenbro J; Borén T; Carlstedt I
    Biochem J; 2004 Dec; 384(Pt 2):263-70. PubMed ID: 15260802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis.
    McGuckin MA; Every AL; Skene CD; Linden SK; Chionh YT; Swierczak A; McAuley J; Harbour S; Kaparakis M; Ferrero R; Sutton P
    Gastroenterology; 2007 Oct; 133(4):1210-8. PubMed ID: 17919495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Helicobacter pylori colonization by an antiulcer agent, sulglycotide.
    Czajkowski A; Piotrowski J; Yotsumoto F; Slomiany A; Slomiany BL
    Biochem Mol Biol Int; 1993 Apr; 29(5):965-71. PubMed ID: 8508147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucolytic effects of Helicobacter pylori.
    Sarosiek J; Peura DA; Guerrant RL; Marshall BJ; Laszewicz W; Gabryelewicz A; McCallum RW
    Scand J Gastroenterol Suppl; 1991; 187():47-55. PubMed ID: 1775924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulglycotide effect on the proteolytic and lipolytic activities of Helicobacter pylori toward gastric mucus.
    Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A; Slomiany BL
    Am J Gastroenterol; 1994 Feb; 89(2):232-6. PubMed ID: 8304309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The microbiology and epidemiology of Helicobacter pylori infection.
    Lee A
    Scand J Gastroenterol Suppl; 1994; 201():2-6. PubMed ID: 8047819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-standing gastric mucosal barrier dysfunction in Helicobacter pylori-induced gastritis in mongolian gerbils.
    Sun YQ; Söderholm JD; Petersson F; Borch K
    Helicobacter; 2004 Jun; 9(3):217-27. PubMed ID: 15165257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in apoptosis and decrease in ornithine decarboxylase activity of the gastric mucosa in patients with atrophic gastritis and gastric ulcer after successful eradication of Helicobacter pylori.
    Hirasawa R; Tatsuta M; Iishi H; Yano H; Baba M; Uedo N; Sakai N
    Am J Gastroenterol; 1999 Sep; 94(9):2398-402. PubMed ID: 10483998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.